Work

Lenvatinib and pembrolizumab in patients with metastatic papillary renal cell carcinoma: A phase 2 pilot study.

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.23_suppl.109

Authors: Ilya Tsimafeyeu, Alexander Sultanbaev, Sergey Vilkov

Institutions: Kidney Cancer Research Bureau, Republican Oncological Clinical Dispensary

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4401516064

Cites:

Cited by:

Related to: 10